These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 3873197

  • 1. Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass.
    Wolk LA, Wilson RF, Burdick M, Selik N, Brown J, Starricco A, Mammen EF.
    Am Surg; 1985 Jun; 51(6):309-13. PubMed ID: 3873197
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass.
    Chandler WL.
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):459-67. PubMed ID: 16085250
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ, Kao RH, Cheng TY, Huang CC, Chang SL, Lee FN.
    Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J, Peltola K, Sairanen H, Leijala M, Kekomäki R, Vahtera E, Siimes MA.
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
    Dial S, Delabays E, Albert M, Gonzalez A, Camarda J, Law A, Menzies D.
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
    Hainaut J, Dhennin C, Guilbaud J.
    Nouv Rev Fr Hematol (1978); 1982 Sep; 24(6):375-81. PubMed ID: 6188103
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rapid quantitation of plasma heparin and antithrombin III levels for cardiopulmonary bypass monitoring, using fluorometric substrate assays.
    Savidge GF, Kesteven PJ, Al-Hasani SF, O'Brien PF.
    Thromb Haemost; 1983 Oct 31; 50(3):745-8. PubMed ID: 6648894
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.